{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:30:33Z","timestamp":1783071033500,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/jp.2016.55","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T14:48:46Z","timestamp":1460040526000},"page":"601-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin"],"prefix":"10.1038","volume":"36","author":[{"given":"A G","family":"Euser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T D","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K D","family":"Heyborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,7]]},"reference":[{"key":"BFjp201655_CR1","unstructured":"World Health Organization. The World Health Report 2005: Make Every Mother and Child Count. 2005. Available at http:\/\/www.who.int\/whr\/2005\/whr2005_en.pdf (accessed 5 October 2015)."},{"key":"BFjp201655_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L . The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130\u2013137.","journal-title":"Semin Perinatol"},{"key":"BFjp201655_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"L Askie","year":"2005","unstructured":"Askie L, Duley L, Henderson-Smart D, Stewart L, Paris Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2005; 369: 1791\u20131798.","journal-title":"Lancet"},{"key":"BFjp201655_CR4","first-page":"1319","volume":"101","author":"A Coomarasamy","year":"2003","unstructured":"Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan K . Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101: 1319\u20131332.","journal-title":"Obstet Gynecol"},{"key":"BFjp201655_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","volume":"161","author":"M Lefevre","year":"2014","unstructured":"Lefevre M, U.S. Preventative Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality. Ann Intern Med 2014; 161: 819\u2013826.","journal-title":"Ann Intern Med"},{"key":"BFjp201655_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. Obstet Gynecol 2010; 116: 402\u2013414.","journal-title":"Obstet Gynecol"},{"key":"BFjp201655_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"J Henderson","year":"2014","unstructured":"Henderson J, Whitlock E, O\u2019Connor E, Senger C, Thompson J, Rowland M . Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventative Services Task Force. Ann Intern Med 2014; 160: 695\u2013703.","journal-title":"Ann Intern Med"},{"key":"BFjp201655_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy","year":"2013","unstructured":"American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122\u20131131.","journal-title":"Obstet Gynecol"},{"key":"BFjp201655_CR9","unstructured":"World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia, 2011. Available at http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548335_eng.pdf (accessed 5 October 2015)."},{"key":"BFjp201655_CR10","doi-asserted-by":"publisher","first-page":"512.e1","DOI":"10.1016\/j.ajog.2014.04.027","volume":"211","author":"T Metz","year":"2014","unstructured":"Metz T, Allshouse A, Euser A, Heyborne K . Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers. Am J Obstet Gynecol 2014; 211: 512.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR11","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2012.06.006","volume":"207","author":"R Olsen","year":"2012","unstructured":"Olsen R, Woelkers D, Dunsmoor-Su R, LaCoursiere Y . Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia. Am J Obstet Gynecol 2012; 207: 228.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","volume":"106","author":"L Dugoff","year":"2005","unstructured":"Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005; 106: 260\u2013267.","journal-title":"Obstet Gynecol"},{"key":"BFjp201655_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1067\/S0002-9378(03)00769-5","volume":"189","author":"S Chandra","year":"2003","unstructured":"Chandra S, Scott H, Dodds L, Watts C, Blight C, Van den Hof M . Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 2003; 189: 775\u2013781.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0029-7844(95)00390-8","volume":"87","author":"PA Benn","year":"1996","unstructured":"Benn PA, Horne D, Briganti S, Rodis JF, Clive JM . Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996; 87: 217\u2013222.","journal-title":"Obstet Gynecol"},{"key":"BFjp201655_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/0002-9378(93)90013-9","volume":"169","author":"TK Sorenson","year":"1993","unstructured":"Sorenson TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE . Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993; 169: 834\u2013838.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199803123381101","volume":"338","author":"S Caritis","year":"1998","unstructured":"Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338: 701\u2013705.","journal-title":"N Engl J Med"},{"key":"BFjp201655_CR17","doi-asserted-by":"publisher","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","volume":"5","author":"RW Powers","year":"2010","unstructured":"Powers RW, Jeyabalan A, Clifton RG, Dorsten P Van, Hauth JC, Klebanoff MA et al. Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010; 5: e13263.","journal-title":"PLoS One"},{"key":"BFjp201655_CR18","first-page":"e1","volume":"200","author":"B Sibai","year":"2009","unstructured":"Sibai B, Romero R, Klebanoff M, Rice MM, Caritis S, Lindheimer MD et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009; 200: e1\u2013630.e8.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0002-9378(98)70130-9","volume":"179","author":"J Hauth","year":"1998","unstructured":"Hauth J, Sibai B, Caritis S, Vandorsten P, Klebanoff M, Macpherson C et al. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. Am J Obstet Gynecol 1998; 179: 1193\u20131199.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0002-9378(98)70146-2","volume":"179","author":"BM Sibai","year":"1998","unstructured":"Sibai BM . Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 1998; 179: 1275\u20131278.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR21","doi-asserted-by":"publisher","first-page":"53.e1","DOI":"10.1016\/j.ajog.2013.03.017","volume":"209","author":"S Maynard","year":"2013","unstructured":"Maynard S, Crawford S, Bathgate S, Yan J, Robidoux L, Moore M et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol 2013; 209: 53.e1\u2013e9.","journal-title":"Am J Obstet Gynecol"},{"key":"BFjp201655_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.placenta.2012.03.003","volume":"33","author":"G Di Lorenzo","year":"2012","unstructured":"Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L et al. First trimester maternal serum PlGF, free beta-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012; 33: 495\u2013501.","journal-title":"Placenta"},{"key":"BFjp201655_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/0002-9378(95)91373-4","volume":"173","author":"KD Wenstrom","year":"1995","unstructured":"Wenstrom KD, Hauth JC, Goldenberg RL, Dubard MB, Lea C . The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels. Am J Obstet Gynecol 1995; 173: 1292\u20131296.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp201655.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201655","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp201655.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:09:52Z","timestamp":1647608992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp201655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,7]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFjp201655"],"URL":"https:\/\/doi.org\/10.1038\/jp.2016.55","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,7]]},"assertion":[{"value":"21 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"These findings of this study were presented at the 62nd Annual Scientific Meeting of the Society for Reproductive Investigation, 25 to 28 March 2015, in San Francisco, CA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}